文献速递腹部技术与安全US

肝移植受者纤维化评估:剪切波弹性成像(SWE)的诊断效能及SWE表现与活检结果的相关性

Assessment of Fibrosis in Liver Transplant Recipients: Diagnostic Performance of Shear Wave Elastography (SWE) and Correlation of SWE Findings With Biopsy Results.
PubMed 文献 · AJR Am J Roentgenol · 2019-10-01

前瞻性研究纳入111例成人肝移植受者,共147次超声SWE检查后行肝活检,以Metavir评分纤维化为参考。SWE中位值≤1.76 m/s对应F0或F1(无或轻微纤维化),>1.76 m/s对应显著纤维化(F2-F4);敏感度0.77、特异度0.79、阳性预测值0.33、阴性预测值0.96。作者结论认为若SWE中位剪切波速度≤1.76,肝移植患者可能免于肝活检。

要点

  • SWE中位剪切波速度≤1.76 m/s提示Metavir F0或F1(无或轻微纤维化),>1.76 m/s提示F2-F4显著纤维化。
  • SWE诊断显著纤维化的阴性预测值高达0.96(95% CI 0.91-0.99),有助于排除显著纤维化。
  • 阳性预测值仅0.33(95% CI 0.19-0.49),SWE高于阈值时需结合活检确认。

核心结论

  • 肝移植患者若超声SWE显示中位剪切波速度≤1.76 m/s(对应Metavir F0或F1,即无或轻微纤维化),可能免于肝活检。

研究设计与样本

  • 前瞻性研究,2015年5月1日至2017年12月31日纳入111例成人肝移植受者(年龄23-79岁),共147次右肝叶超声SWE检查后行肝活检,以活检组织Metavir纤维化评分为参考标准;采用分类与回归树分析锚定纤维化程度确定SWE阈值。

诊断标准与关键数值

  • 以SWE中位值1.76 m/s为阈值区分无或轻微纤维化(Metavir F0-F1)与显著纤维化(Metavir F2-F4);敏感度0.77(95% CI 0.5-0.93),特异度0.79(95% CI 0.71-0.86),阳性预测值0.33(95% CI 0.19-0.49),阴性预测值0.96(95% CI 0.91-0.99);总体预测准确度以ROC曲线AUC估计(原文未报告具体AUC数值)。

临床应用与阅片要点

  • 作者认为,肝移植患者超声SWE显示中位剪切波速度≤1.76 m/s(对应Metavir F0或F1)时可能免于肝活检;SWE高于阈值时阳性预测值仅0.33,提示需结合活检确认显著纤维化。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE. Liver transplant patients are monitored for rejection and hepatic fibrosis and often undergo liver biopsies. The purpose of the present study is to determine whether noninvasive shear wave elastography (SWE) can quantify fibrosis in liver transplant recipients, with the aim of decreasing and possibly eliminating unnecessary biopsies for patients with suspected or progressive hepatic fibrosis. MATERIALS AND METHODS. Between May 1, 2015, and December 31, 2017, our prospective study evaluated 111 adult liver transplant patients (age range, 23-79 years) who underwent 147 ultrasound (US) SWE examinations of the right hepatic lobe followed by biopsies. SWE values were compared with the histologic fibrosis (Metavir) scores of the biopsy samples. SWE threshold values were determined using classification and regression tree analysis by anchoring to the degree of fibrosis. The sensitivity, specificity, positive predictive value, and negative predictive value (with 95% CIs) were calculated on the basis of the threshold value. Overall prediction accuracy was estimated using the AUC value from the ROC curve. RESULTS. From the 147 US SWE examinations and liver biopsies, consistent threshold values were identified for patients with no or minimal fibrosis (Metavir scores of F0 and F1, respectively) compared with significant fibrosis (Metavir scores of F2, F3, or F4). A median SWE value of 1.76 m/s or less denoted no or minimal fibrosis, whereas a value greater than 1.76 m/s denoted significant fibrosis. The sensitivity of US SWE examinations in classifying fibrosis was 0.77 (95% CI, 0.5-0.93). The specificity, positive predictive value, and negative predictive value were 0.79 (95% CI, 0.71-0.86), 0.33 (95% CI, 0.19-0.49), and 0.96 (95% CI, 0.91-0.99), respectively. CONCLUSION. Liver transplant patients may avoid liver biopsy if US SWE examination shows a median shear wave velocity of 1.76 or less, which corresponds to a Metavir score of F0 or F1, denoting no or minimal fibrosis.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Deurdulian C, Grant EG, Tchelepi H, et al. Assessment of Fibrosis in Liver Transplant Recipients: Diagnostic Performance of Shear Wave Elastography (SWE) and Correlation of SWE Findings With Biopsy Results. AJR Am J Roentgenol. 2019. PMID: 31573849. doi:10.2214/AJR.19.21160

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。